首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 197 毫秒
1.
以廉价易得的甘氨酸为原料,经酯化、甲酰化、脱水、酰氨化得到异氰基乙酰胺,四步总收率42.9%.异氰基乙酰胺与氨基腈在碱性条件下环合得到重要中间体5-氨基-4-咪唑甲酰胺,收率68.2%.随后经重氮化,与二甲胺偶联,得最终产物达卡巴嗪,总收率22.3%.所有中间体以及目标产物的结构均由1H NMR,13C NMR和ESI-MS确证.合成路线具有原料廉价、反应条件温和、总收率较高等特点,是一条经济实用的合成工艺路线.  相似文献   

2.
彭子祥  刘丹  王瑶琼  刘进兵 《合成化学》2022,30(11):902-908
依匹哌唑是首个治疗精神分裂症的多巴胺、部分5-HT1A受体激动剂和5-HT2A受体拮抗剂类化合物,然而其目前的生产路线存在成本高及收率低等缺点。本文在文献方法的基础上,设计了一条合成依匹哌唑的新路线:以4-取代丁腈和7-羟基喹啉-2-(1H)酮为起始原料,经氧烃基化反应得醚化物1,将醚化物1氰基还原得到氨基物2,氨基物2与Boc-双氯乙基亚胺关环得环合物3,环合物3经脱保护得化合物4,化合物4与4-溴苯并噻吩反应得到目标产物依匹哌唑,采用核磁共振和质谱确证了中间体和目标产物的结构,目标产物纯度高达99.30%,且此合成路线具有操作简单、反应易控、原料易得、产物易分离以及环境友好等优点。  相似文献   

3.
本文探索了合成白藜芦醇的新方法。以3,5-二甲氧基苯胺为原料,经重氮化、还原及乙酰化得到中间体N′-乙酰基-3,5-二甲氧基苯肼(4),中间体4与4-甲氧基苯乙烯经Mizoroki-Heck偶联反应得中间体5,脱去甲基即得到目标产物白藜芦醇,总收率约31.9%。中间体及目标产物的结构均经质谱及核磁氢谱确证。该路线操作简便、条件温和,可用于白藜芦醇的放大制备。  相似文献   

4.
以苯胺为原料,经重氮化、偶合、还原得到4-羟基-5-乙氧基苯胺。合成中,通过保险粉还原偶氮化合物的方法在芳香环上引进氨基,不仅产物收率高(总收率86%,较文献提高了26.3%),而且还原产物容易分离,粗品纯度可达95%。本合成路线中间体均不经提纯,且氨基的引入中避免了贵金属的加氢还原,是一条适合大规模生产4-羟基-5-乙氧基苯胺的新合成工艺路线。  相似文献   

5.
陈莉  柏春美  崔冬梅 《合成化学》2011,19(1):139-141
以2-氨基噻唑为原料,经Boc保护、溴代、氟代和脱保护成盐反应合成了制备葡萄糖激酶激活剂的重要中间体--2-氨基-5-氟噻唑盐酸盐,总收率55%,其结构经1H NMR表征.  相似文献   

6.
以苯酚为原料,氘代碘甲烷与氘代醋酸酐为氘代试剂.经过氘代甲基化、傅克酰基化、克脑文盖尔缩合、芳构化、还原及氘代乙酰化反应得到氘代标记的阿戈美拉汀(1).该合成路线简洁,原料易得、反应条件易于控制,总收率为15.2%,化学纯度为99.97%,氘代丰度大于98%.目标化合物结构经质谱、核磁共振等表征确定可用于其药代动力学研究.  相似文献   

7.
以2-氨基-5-巯基-1,3,4-噻二唑为原料,经氯代频呐酮取代,溴代、硫脲环合得到中间体,再与一系列芳香醛和亚膦酸酯反应合成了7种目标化合物,并用元素分析、质谱和核磁共振氢谱对化合物进行了表征,生物活性实验证明,该类化合物10mg/L表现出较好的生长素活性和细胞分裂素活性.  相似文献   

8.
设计了多种合成路线制备芳香炔基树枝状化合物中间体1,3,5-三[(4’-乙炔基苯基)乙炔基]苯,通过一系列的合成路线和反应条件的对比,发现多官能团的端基炔化合物与芳基溴化合物之间发生多重Sonogashira反应时,常会生成不同取代程度的极性相似化合物,因而难以分离.采用多官能团的端基炔化合物与芳基碘化合物反应可以避免这种情况.最终确定以1,3,5-三溴苯和2-甲基-3-丁炔-2-醇为原料,制得中间产物1,3,5-三乙炔基苯;再以对碘苯胺和三甲基硅乙炔为原料,经重氮化化、卤代反应制得4-三甲基硅乙炔基碘苯;后者与1,3,5-三乙炔苯经Sonogashira反应、裂解去保护反应,制得化合物1,3,5-三[(4’-乙炔基苯基)乙炔基]苯.用1H NMR,13C NMR,元素分析等表征手段确认了中间体及最终产物的结构.  相似文献   

9.
大黄酚和大黄酸的合成   总被引:1,自引:0,他引:1  
马燕如  赵肖玉  徐正 《合成化学》2007,15(2):244-246
以3-硝基邻苯二甲酸为原料,经脱水、傅克酰基化、还原、重氮化、水解和环合反应合成了大黄酚(6),总收率40.4%。6再经乙酰化、氧化、脱乙酰化反应合成了大黄酸(8),总收率22.3%。6和8的结构经1H NMR表征。  相似文献   

10.
合成考尼伐坦关键中间体2-甲基-6-(4-甲基苯磺酰基)-1,4,5,6-四氢咪唑[4,5-d][1]苯并氮杂卓并对其工艺优化。以氨茴酸甲酯为起始原料,经保护、烃化、环合、脱羧、溴化、烃化并缩合共六步反应合成考尼伐坦关键中间体。所得的目标化合物经核磁共振氢谱、质谱确认,总收率达49.06%。该关键中间体合成方法和工艺改进后,所用原料价格便宜、反应条件温和、反应周期缩短、产率提高,更加适合于工业化生产。  相似文献   

11.
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine is the key intermediate of Silodosin, the α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia. In order to obtain this intermediate, we developed a novel synthetic route by utilizing 2- nitrochlorobenzene as the starting material via O-alkylation, reduction, diazotization, acidolysis, etherification, condensation and hydrazinolysis. The highlight of this method lies on its convenience and economy in accessing this intermediate. 2007 Guo Hua Chert. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.  相似文献   

12.
The synthesis of substituted aza- and oxaazaisowurtzitanes via direct condensation is challenging. The selection of starting ammonia derivatives is very limited. The important step in developing alternative synthetic routes to these compounds is a detailed study on their formation process. Here, we explored an acid-catalyzed condensation between 4-tert-butyl-2,6-dimethylbenzenesulfonamide and glyoxal in aqueous H2SO4, aqueous acetonitrile and acetone, and established some new processes hindering the condensation. In particular, an irreversible rearrangement of the condensation intermediate was found to proceed and be accompanied by the 1,2-hydride shift and by the formation of symmetric disulfanes and sulfanes. It has been shown for the first time that aldehydes may act as a reducing agent when disulfanes are generated from aromatic sulfonamides, as is experimentally proved. The condensation between 4-tert-butyl-2,6-dimethylbenzenesulfonamide and formaldehyde resulted in 1,3,5-tris((4-(tert-butyl)-2,6-dimethylphenyl)sulfonyl)-1,3,5-triazinane. It was examined if diimine could be synthesized from 4-tert-butyl-2,6-dimethylbenzenesulfonamide and glyoxal by the most common synthetic procedures for structurally similar imines. It has been discovered for the first time that the Friedel–Crafts reaction takes place between sulfonamide and the aromatic compound. A new synthetic strategy has been suggested herein that can reduce the stages in the synthesis of in-demand organic compounds of symmetric and asymmetric aromatic sulfones via the Brønsted acid-catalyzed Friedel–Crafts reaction, starting from aromatic sulfonamides and arenes activated towards an electrophilic attack.  相似文献   

13.
A modified synthetic route to isocardenolide (I) via furan intermediate (6) was studied. The diene (4) could easily be synthesized from carbinol (1) or acetate (2). Dissolving metal reduction of diene (4) to Δ1, 17β-furyl compound (6) was successfully achieved.  相似文献   

14.
用一种新的简便方法对Verbenachalcone进行全合成, 针对目标物的结构特征, 将其切为2个合成片段, 即化合物4和6, 然后再将2个片段连接. 从对羟基苯甲醛(2)开始经过溴代、乙酰化、Ullmann反应、甲氧甲基化、羟醛缩合、脱保护和催化加氢等7步反应完成了标题化合物的全合成, 总收率为39.1%, 合成的关键步骤是3-溴-4-羟基苯甲醛(3)和香兰素进行的Ullmann反应. 关键中间体与最终产物的化学结构经1H NMR, 13C NMR和ESI-MS等表征确认.  相似文献   

15.
李翠勤  李杨  孙鹏  黄金  王俊  李锋 《分子科学学报》2020,(2):170-176,I0006
采用2-甲基-6-叔丁基苯酚和丙烯酸甲酯为原料,通过迈克尔加成反应合成半受阻酚类抗氧剂中间体β-(3-甲基-5-叔丁基-4-羟基苯基)丙酸甲酯.条件优化实验确定该抗氧剂中间体的最佳合成工艺条件为:2-甲基-6-叔丁基苯酚与丙烯酸甲酯物质的量之比为1∶1.1,催化剂KOH与2-甲基-6-叔丁基苯酚的物质的量比为1∶10,丙烯酸甲酯滴加温度为90℃,丙烯酸甲酯滴加时间为30 min,反应温度为130℃,反应时间为5 h.在此条件下,半受阻酚类抗氧剂中间体β-(3-甲基-5-叔丁基-4-羟基苯基)丙酸甲酯的收率大于70%,熔程41.6℃~44.0℃.IR和1H NMR证实所合成目标产物的化学结构与其理论结构相一致.DPPH法测定半受阻酚类抗氧剂中间体清除自由基的性能,并与全受阻酚类抗氧剂中间体β-(3,5-二叔丁基-4-羟基苯基)丙酸甲酯进行对比.结果表明,由于邻位取代基的不对称效应,使得空间位阻较小的不对称抗氧剂中间体β-(3-甲基-5-叔丁基-4-羟基苯基)丙酸甲酯清除DPPH·的活性高于邻位取代基空间位阻较大的对称抗氧剂中间体清除DPPH·的活性.  相似文献   

16.
以丙炔醇为原料, 经Mannich反应、还原、溴化、Williamson合成法等共七步反应, 首次合成了从海洋真菌中分离的天然产物联烯Xyloallenoid F, 总收率25.4%, 目标化合物经IR, 1H NMR, 13C NMR, MS和元素分析进行测定和结构表征.  相似文献   

17.
cis-BCH-189 are potent anti-HIV agents and have been synthesized from mannose1 galactose2 or glucose3 etc. Owing to so many synthetic steps, it is difficult and expensive to obtain a few grams. In this paper, we have designed new route and promoted the reaction conditions for the synthesis of this nucleoside cis- (+)- BCH-189 from cheap starting material via a four step route as shown in Scheme 1. By this method, a series of derivatives of title compound can be synthesized conviniently for…  相似文献   

18.
Ionic telomerization of 1-chloro-2,3-epoxypropane with allyl alcohol in the presence of boron trifluoride etherate as a route to halogenated epoxy oligoethers was studied. Selective chlorination or bromination of the intermediate oligo(chlorohydrin), followed by dehydrochlorination (epoxidation) of the intermediate oligohalohydrins with NaOH, was performed. The synthesized products are effi cient as active diluents for a compound based on ED-20 resin.  相似文献   

19.
Two different synthetic routes were explored for the synthesis of fluoro furanyl norprogesterone (FFNP) 1, a high-affinity ligand for the progesterone receptor (PgR) that is being developed as a PET imaging agent for PgR-positive breast cancer. Both approaches proceed through a key intermediate, triol 5. The first approach, starting from keto-ketal 2, employed a dioxenyl group as a synthon for installing a corticosteroid side chain in keto-alcohol 4. The second approach, starting from propargylic acetate 12b, involved the application of a two-step method, a Pd(II)-catalyzed oxidative rearrangement followed by a base-catalyzed acetate rearrangement of the intermediate unsaturated acetate 13b, to generate the requisite corticosteroid side chain in keto-acetate 14b. This intermediate was further elaborated to the final product 1 via efficient dihydroxylation with potassium permangnate, furan acetalization with scandium triflate, and mesylation and fluorination reactions. The palladium-catalyzed route is considerably more efficient than the dioxene approach for the synthesis of key intermediate triol 5, and the scandium triflate-catalyzed acetalization, in particular, led to a considerable improvement in the overall yield of the endo furan acetal alcohol 16a. This route provides a major improvement in the overall yield of the final progestin target, FFNP 1.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号